In terms of age, the hepcidin level was significantly elevated in the lung cancer tissues of patients from different age groups (21-40 years, 41-60 years, 61-80 years and 81-100 years in LUAD; 61-80 years in LUSC) (Supplementary Figure 2B). The gene discussed is HAMP; the disease is lung carcinoma.